The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Celex Oncology’s first attendance at Bio-Europe Spring 2025 follows their recent win at the 2024 EIT Health Catapult ...

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...

Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both ...

Festivals like Aadi Mahotsav foster cultural exchange and sustainable development, aligning with SDG 17 by promoting ...

Metabolic Associated Fatty Liver Disease (MAFLD) has emerged as a global public health concern due to its increasing ...

Interim Analysis Expected End of 2Q 2025BETHESDA, MD, Mar 14, 2025 - (ACN Newswire) - Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading ...

Hypnosis has long been recognized as a powerful tool for personal transformation, healing, and overcoming challenges. Among ...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, and the Australian Centre for the Prevention of Cervical Cancer (ACPCC) with its Australian HPV Reference Laboratory, ...

Therapy intensives claim to deliver faster results than weekly therapy—but are they truly effective? Explore the research ...